Madison Avenue Partners, LP Theravance Biopharma, Inc. Transaction History
Madison Avenue Partners, LP
- $774 Million
- Q1 2025
A detailed history of Madison Avenue Partners, LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 9,511,150 shares of TBPH stock, worth $108 Million. This represents 10.97% of its overall portfolio holdings.
Number of Shares
9,511,150
Previous 9,511,150
-0.0%
Holding current value
$108 Million
Previous $89.5 Million
5.1%
% of portfolio
10.97%
Previous 14.29%
Shares
6 transactions
Others Institutions Holding TBPH
# of Institutions
137Shares Held
47.3MCall Options Held
700Put Options Held
1.4K-
Weiss Asset Management LP Boston, MA7.46MShares$84.6 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$54 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$42.9 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$31.3 Million3.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$23.6 Million0.0% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $758M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...